← Open Payments lookup

ANGEL GUAN: Open Payments

NPI 1346813847 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,917 in 62 payments from 10 companies in 2025. Trend: 2023 $1,381 · 2024 $1,553 · 2025 $2,917

Food & beverage: $2,917
CompanyPaymentsAmount
Madrigal Pharmaceuticals28$1,346
Mirum Pharmaceuticals, Inc.6$545
Gilead Sciences, Inc.6$370
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$252
Intercept Pharmaceuticals, Inc.1$150
Amgen Inc.1$122
ABBVIE INC.2$48
Invivyd Inc1$33
Ipsen Biopharmaceuticals, Inc1$30
Mallinckrodt Hospital Products Inc.1$22

Products named: REZDIFFRA, Livmarli, Livdelzi, XIFAXAN, OCALIVA, MAVYRET, PEMGARDA, IQIRVO.

Industry payments across NY — which companies pay providers there.